• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身磁共振成像联合扩散加权成像在骨转移瘤中的应用:一篇叙述性综述

Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review.

作者信息

Stecco Alessandro, Trisoglio Alessandra, Soligo Eleonora, Berardo Sara, Sukhovei Lidiia, Carriero Alessandro

机构信息

Ospedale Maggiore della Carità di Novara, Istituto di Radiodiagnostica ed Interventistica, Università del Piemonte Orientale, Amedeo Avogadro, Corso Giuseppe Mazzini 18, 28100 Novara, Italy.

出版信息

Diagnostics (Basel). 2018 Jul 9;8(3):45. doi: 10.3390/diagnostics8030045.

DOI:10.3390/diagnostics8030045
PMID:29987207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6163267/
Abstract

Whole body magnetic resonance imaging (MRI) with diffusion-weighted imaging (WB-MRI-DWI) is currently emerging as a diagnostic technique in the evaluation of bone metastases from breast, prostate, lung, thyroid, and melanoma tumors. The most relevant articles regarding the detection of solid tumor bone metastases with MRI have been reviewed and cited. The imaging methods currently used in the detection of bone metastases are bone scintigraphy, computed tomography (CT), and positron emission tomography (PET/CT) with 2-deoxy-2-[fluorine-18] fluoro-d-glucose (18F-FDG PET/CT). WB-MRI-DWI allows qualitative and quantitative evaluation of focal lesions through signal intensity evaluation on DWI images and the reconstruction of the apparent diffusion coefficient (ADC) map. In prostate and breast cancer, WB-MRI-DWI is useful in assessing the response of bone lesions to therapy and to detecting early non-responders, while in lung cancer the method shows a similar sensitivity to 18F-FDG PET/CT in the detection of bone metastases. In bone metastases of thyroid tumors and melanoma, the WB-MRI-DWI shows a higher sensitivity when compared to 18F-FDG PET/CT. With a standardization of the WB-MRI-DWI protocol, this method seems to play an important role in the diagnosis of bone solid tumor metastases.

摘要

全身磁共振成像(MRI)结合扩散加权成像(WB-MRI-DWI)目前正成为一种用于评估乳腺癌、前列腺癌、肺癌、甲状腺癌和黑色素瘤骨转移的诊断技术。已对有关用MRI检测实体瘤骨转移的最相关文章进行了综述和引用。目前用于检测骨转移的成像方法有骨闪烁显像、计算机断层扫描(CT)以及用2-脱氧-2-[氟-18]氟-D-葡萄糖(18F-FDG PET/CT)的正电子发射断层扫描(PET/CT)。WB-MRI-DWI可通过对DWI图像上的信号强度进行评估以及重建表观扩散系数(ADC)图,对局灶性病变进行定性和定量评估。在前列腺癌和乳腺癌中,WB-MRI-DWI有助于评估骨病变对治疗的反应并检测早期无反应者,而在肺癌中,该方法在检测骨转移方面显示出与18F-FDG PET/CT相似的敏感性。在甲状腺肿瘤和黑色素瘤的骨转移中,与18F-FDG PET/CT相比,WB-MRI-DWI显示出更高的敏感性。随着WB-MRI-DWI方案的标准化,该方法似乎在骨实体瘤转移的诊断中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/b84dd1ea0d6b/diagnostics-08-00045-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/eca5d11f67ea/diagnostics-08-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/2dc6c60c4a93/diagnostics-08-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/c50dd7ecbc04/diagnostics-08-00045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/30b4711d454d/diagnostics-08-00045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/b84dd1ea0d6b/diagnostics-08-00045-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/eca5d11f67ea/diagnostics-08-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/2dc6c60c4a93/diagnostics-08-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/c50dd7ecbc04/diagnostics-08-00045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/30b4711d454d/diagnostics-08-00045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bf/6163267/b84dd1ea0d6b/diagnostics-08-00045-g005.jpg

相似文献

1
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review.全身磁共振成像联合扩散加权成像在骨转移瘤中的应用:一篇叙述性综述
Diagnostics (Basel). 2018 Jul 9;8(3):45. doi: 10.3390/diagnostics8030045.
2
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.18F-FDG PET/CT 和全身 MRI 在非小细胞肺癌 M 分期中的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2020 Jul;30(7):3641-3649. doi: 10.1007/s00330-020-06703-1. Epub 2020 Mar 3.
3
Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer.全身扩散加权成像与 18F-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描或计算机断层扫描在胃肠道癌症患者中检测肿瘤复发和转移的诊断效能比较。
Gastroenterol Rep (Oxf). 2015 May;3(2):128-35. doi: 10.1093/gastro/gou078. Epub 2014 Nov 17.
4
Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus F-FDG PET/CT for Detection of Bone Metastases.全身弥散加权成像(背景抑制)联合 3T 下表观弥散系数计算与 F-FDG PET/CT 检测骨转移的诊断价值。
AJR Am J Roentgenol. 2020 Feb;214(2):446-454. doi: 10.2214/AJR.19.21656. Epub 2019 Dec 4.
5
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.全身多参数 MRI 弥散加权成像及 ADC 图在识别实体瘤内脏及骨转移中的应用。
Acad Radiol. 2018 Nov;25(11):1405-1414. doi: 10.1016/j.acra.2018.02.010. Epub 2018 Apr 4.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?全身扩散加权成像与 FDG-PET 检测非小细胞肺癌:孰优孰劣?
Magn Reson Imaging. 2010 Jun;28(5):613-20. doi: 10.1016/j.mri.2010.02.009. Epub 2010 Apr 24.
8
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.扩散加权磁共振成像(DWI)与 FDG PET/CT 用于全身乳腺癌分期的诊断价值比较。
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1077-86. doi: 10.1007/s00259-010-1399-z. Epub 2010 Mar 4.
9
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.在专用全身磁共振/正电子发射断层扫描系统中对肺部病变进行同时采集的弥散加权成像和 2-脱氧-[18F]氟-2-D-葡萄糖正电子发射断层扫描的相关性研究。
Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.
10
Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.非小细胞肺癌患者骨转移的检测:全身扩散加权成像(DWI)、有无DWI的全身磁共振成像、全身氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)及骨闪烁显像的比较
J Magn Reson Imaging. 2009 Aug;30(2):298-308. doi: 10.1002/jmri.21858.

引用本文的文献

1
Whole-body magnetic resonance imaging for cutaneous melanoma staging: A scientific review.用于皮肤黑色素瘤分期的全身磁共振成像:一项科学综述。
World J Clin Oncol. 2025 Aug 24;16(8):109206. doi: 10.5306/wjco.v16.i8.109206.
2
The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review.全身磁共振成像在淋巴瘤患者中的作用:一项叙述性综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251359724. doi: 10.1177/15330338251359724. Epub 2025 Aug 17.
3
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition).

本文引用的文献

1
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.全身多参数 MRI 弥散加权成像及 ADC 图在识别实体瘤内脏及骨转移中的应用。
Acad Radiol. 2018 Nov;25(11):1405-1414. doi: 10.1016/j.acra.2018.02.010. Epub 2018 Apr 4.
2
Breast cancer bone metastases: pathogenesis and therapeutic targets.乳腺癌骨转移:发病机制和治疗靶点。
Int J Biochem Cell Biol. 2018 Mar;96:63-78. doi: 10.1016/j.biocel.2018.01.003. Epub 2018 Jan 5.
3
11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer.
《中国肺癌骨转移诊疗专家共识(2022年版)》
J Natl Cancer Cent. 2023 Aug 19;3(4):256-265. doi: 10.1016/j.jncc.2023.08.004. eCollection 2023 Dec.
4
An objective measure of response on whole-body MRI in metastatic hormone sensitive prostate cancer treated with androgen deprivation therapy, external beam radiotherapy, and radium-223.雄激素剥夺治疗、外照射放疗和镭-223 治疗转移性激素敏感前列腺癌的全身 MRI 反应的客观测量。
Br J Radiol. 2024 Mar 28;97(1156):794-802. doi: 10.1093/bjr/tqae005.
5
The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer.重编程葡萄糖代谢的潜在作用:甲状腺癌中新出现的可操作的共依赖靶点。
J Transl Med. 2023 Oct 18;21(1):735. doi: 10.1186/s12967-023-04617-2.
6
Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.全身 MRI 评估包括扩散加权序列在高转移风险乳腺癌患者初始分期中的应用与 PET-CT 的对比:一项前瞻性队列研究。
Eur Radiol. 2024 Jan;34(1):165-178. doi: 10.1007/s00330-023-10060-0. Epub 2023 Aug 9.
7
Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study).姑息性放疗治疗骨转移瘤的磁共振成像评估:一项关于临床与影像学评估一致性的多中心前瞻性研究(MARTE研究)
Diagnostics (Basel). 2023 Jul 10;13(14):2334. doi: 10.3390/diagnostics13142334.
8
Evaluating prostate cancer bone metastasis using accelerated whole-body isotropic 3D T1-weighted Dixon MRI with compressed SENSE: a feasibility study.使用具有压缩灵敏度编码的加速全身各向同性三维T1加权狄克逊磁共振成像评估前列腺癌骨转移:一项可行性研究。
Eur Radiol. 2023 Mar;33(3):1719-1728. doi: 10.1007/s00330-022-09181-9. Epub 2022 Oct 21.
9
Biological and Clinical Aspects of Metastatic Spinal Tumors.转移性脊柱肿瘤的生物学和临床方面
Cancers (Basel). 2022 Sep 22;14(19):4599. doi: 10.3390/cancers14194599.
10
Percutaneous CT-Guided Bone Lesion Biopsy for Confirmation of Bone Metastases in Patients with Breast Cancer.经皮CT引导下骨病变活检以确诊乳腺癌患者的骨转移
Diagnostics (Basel). 2022 Aug 29;12(9):2094. doi: 10.3390/diagnostics12092094.
对复发性前列腺癌患者进行11C-胆碱PET/CT及包括弥散加权成像在内的全身MRI检查。
Oncotarget. 2017 Mar 15;8(39):66516-66527. doi: 10.18632/oncotarget.16227. eCollection 2017 Sep 12.
4
Rationale for Modernising Imaging in Advanced Prostate Cancer.在晚期前列腺癌中进行影像学现代化的理由。
Eur Urol Focus. 2017 Apr;3(2-3):223-239. doi: 10.1016/j.euf.2016.06.018. Epub 2016 Jul 15.
5
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.晚期前列腺癌患者的管理:2017 年晚期前列腺癌共识会议(APCCC)报告。
Eur Urol. 2018 Feb;73(2):178-211. doi: 10.1016/j.eururo.2017.06.002. Epub 2017 Jun 24.
6
The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.在全身计算机断层扫描中加入全身磁共振成像会改变转移性乳腺癌患者的治疗决策。
Eur J Cancer. 2017 May;77:109-116. doi: 10.1016/j.ejca.2017.03.001. Epub 2017 Apr 5.
7
Detection of Prostate Cancer Metastasis by Whole Body Magnetic Resonance Imaging Combined with Bone Scintigraphy and PSA Levels.全身磁共振成像联合骨闪烁显像及前列腺特异抗原水平检测前列腺癌转移
Cell Physiol Biochem. 2016;40(5):1052-1062. doi: 10.1159/000453161. Epub 2016 Dec 12.
8
Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment.未增强全身磁共振成像与正电子发射断层扫描-计算机断层扫描在原发性治疗后前列腺癌转移灶检测中的比较
Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3770-3776.
9
Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.18F-氟化钠和18F-氟胆碱PET/CT对前列腺癌骨转移的评估
J Nucl Med. 2016 Oct;57(Suppl 3):55S-60S. doi: 10.2967/jnumed.115.169730.
10
Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy: Evidence From a Meta-Analysis.扩散加权磁共振成像在骨恶性肿瘤中的诊断性能:一项荟萃分析的证据
Medicine (Baltimore). 2015 Nov;94(45):e1998. doi: 10.1097/MD.0000000000001998.